Director/PCA Dealing
CEO Dr Juho Jalkanen acquired 22,127 shares at €2.26 per share on 27 June 2025.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
| Faron Pharmaceuticals Ltd | Company announcement | June 30, 2025 at 14:00:00 EEST |
TURKU, FINLAND – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, announces today that Dr Juho Jalkanen, Chief Executive Officer of the Company, acquired 22,127 ordinary shares in Faron at price of €2.26 per share on 27 June 2025. Following this purchase, Dr Jalkanen directly holds 1,112,015 ordinary shares in the Company, representing 0.99 per cent of the voting rights in the Company.
Additionally, Dr Juho Jalkanen acquired 2,000 ordinary shares in Faron at a price of 2.27 EUR per share on 27 June 2025 on behalf of his daughter.
Further details are set out in the Notification of Dealing Form below.
| Director/PCA | Holding prior to purchase | Number of ordinary shares | Resultant interest in ordinary shares in the Company | Resultant percentage of voting rights in the Company |
| Juho Jalkanen | 1,089,888 | 22,127 | 1,112,015 | 0.99% |
| Evelina Jalkanen* | Nil | 2,000 | 2,000 | 0,00% |
| *Individuals deemed as a PCA to Juho Jalkanen | ||||
| a. | Name | a) Juho Jalkanen b) Eveliina Jalkanen | ||
| 2 | Reason for notification | |||
| a. | Position/Status | a) Chief Executive Officer b) PCA | ||
| b. | Initial notification/ Amendment | Initial Notification | ||
| a. | Name | Faron Pharmaceuticals Ltd. | ||
| b. | LEI | 7437009H31TO1DC0EB42 | ||
| a. | Description of the financial instrument, type of instrument Identification Code | Ordinary Shares ISIN: FI4000153309 | ||
| b. | Nature of the transaction | Purchase of ordinary shares | ||
| Price(s) per share (p) | Volume(s) | |||
| a) €2.26 b) €2.27 | a) 22,127 b) 2,000 | |||
| d. | Aggregated information Volume Price | Transaction details (a) (1): Volume 22,217 Unit price: 2.26 EUR Transaction details (b) (1): Volume 2,000 Unit price: 2.27 EUR | ||
| f. | Place of the transaction | Nasdaq First North Growth Market | ||
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.